Central Lab Market to Reach $5.95 Billion, Globally, by 2031 at 6.0% CAGR: Allied Market Research

The global central lab market is experiencing growth due to increasing investments in research and development, clinical trials, and the demand for innovative treatments for various diseases.


Portland, OR, April 18, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled,Central Lab Market by Services (Genetic Services, Biomarker Services, Anatomic Pathology and Histology, Specimen Management &Storage, and Others), and by End User (Pharmaceutical Companies, Biotechnology Companies and Others): Global Opportunity Analysis and Industry Forecast, 2022–2031”. According to the report, the global central lab industry generated $3.31 billion in 2021 and is anticipated to generate $5.95 billion by 2031, witnessing a CAGR of 6.0% from 2022 to 2031.

Request Sample PDF - https://www.alliedmarketresearch.com/request-sample/15775

Prime determinants of growth

The global central lab market is experiencing growth due to increasing investments in research and development, clinical trials, and the demand for innovative treatments for various diseases. Additionally, outsourcing of central labs is gaining popularity as it improves efficiency, reduces costs, and provides access to specialized expertise and technology. However, logistical and sample-handling issues are limiting the market growth. Nevertheless, emerging markets present significant growth opportunities for the central lab market in the foreseeable future.

Report coverage & details:

Report CoverageDetails
Forecast Period2022–2031
Base Year2021
Market Size in 2021$3.31 billion
Market Size in 2031$5.95 billion
CAGR6%
No. of Pages in Report220
Segments coveredServices, End User, and Region.
Drivers Rising investments in R&D and clinical trials

The surge in the outsourcing of central labs

Increase in demand for novel drugs
OpportunitiesGrowth opportunities in emerging markets
RestraintsIssues with logistics and sample handling

Impact of COVID-19 on Central Lab Market-

  • The central lab market encountered various challenges during the pandemic, including supply chain disruptions and delayed clinical trials. The management of research activities and clinical trials was also impacted by travel restrictions, social distancing measures, and other pandemic-related obstacles.
  • Despite these challenges, central labs were able to contribute to the pandemic response by providing diagnostic testing for COVID-19 and supporting the development of potential treatments and vaccines. As a result, the pandemic also presented opportunities for central labs in terms of vaccine manufacturing and development.

Procure Complete Report (223 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/central-lab-market

The biomarker services segment to maintain its leadership status throughout the forecast period

Based on services, the biomarker services segment held the largest share in 2021, accounting for more than two-fifths of the global central lab market revenue, and is projected to manifest the highest CAGR of 6.4% during the forecast period, owing to the increasing use of biomarkers in drug development & clinical research.

The pharmaceutical companies’ segment to maintain its lead position during the forecast period

Based on end user, the pharmaceutical companies segment accounted for the largest share in 2021, contributing to more than two-fifths of the global central lab market revenue, and is expected to portray the fastest CAGR of 6.4% during the forecast period, due to rise in the number of clinical trials for new drugs, increase in investments in R&D activities, and surge in the prevalence of chronic diseases.

North America to maintain its dominance by 2031

Based on region, North America held the highest market share in terms of revenue in 2021, generating nearly two-fifths of the global central lab market revenue, owing to strong presence of key players along with the availability of advanced technologies and rise in government initiatives promoting research activities for the development of novel drugs.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15775

Asia-Pacific region is expected to witness the fastest CAGR of 6.6% from 2022 to 2031, and is likely to dominate the market during the forecast period, owing to an increase in the number of clinical studies, rising number of central labs services provider companies, increasing investments in pharmaceutical R&D activities, and favorable regulatory guidelines for clinical trials in the region.

Leading Market Players: -

  • Eurofins Scientific
  • ICON Plc
  • Medpace
  • Rochester Regional Health (ACM Global Laboratories)
  • IQVIA Inc. (Q2 Solutions)
  • LabConnect
  • Cerba Healthcare (Cerba Research)
  • Frontage Labs
  • CIRION BioPharma Research Inc.
  • Laboratory Corporation of America Holdings

The report provides a detailed analysis of these key players in the global central lab market. These players have adopted different strategies such as acquisition, expansion, and agreements, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry-

Meniscus Repair System Market - Opportunity Analysis and Industry Forecast, 2021–2031

Motorized Prosthesis Market- Opportunity Analysis and Industry Forecast, 2021–2031

Skincare Market - Global Opportunity Analysis and Industry Forecast, 2021–2031

Local Anesthesia Drugs Market- Global Opportunity Analysis and Industry Forecast, 2021–2031

Healthcare Staffing Market - Global Opportunity Analysis and Industry Forecast, 2021–2031

                                                                                 
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com